These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 15988069)
41. Determinants for phosphodiesterase 6 inhibition by its gamma-subunit. Zhang Z; Artemyev NO Biochemistry; 2010 May; 49(18):3862-7. PubMed ID: 20397626 [TBL] [Abstract][Full Text] [Related]
42. Catalytic Domains of Phosphodiesterase 5, 6, and 5/6 Chimera Display Differential Dynamics and Ligand Dissociation Energy Barriers. Pattis JG; Kamal S; Li B; May ER J Phys Chem B; 2019 Jan; 123(4):825-835. PubMed ID: 30616346 [TBL] [Abstract][Full Text] [Related]
43. Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects. Foresta C; Caretta N; Zuccarello D; Poletti A; Biagioli A; Caretti L; Galan A Eye (Lond); 2008 Jan; 22(1):144-9. PubMed ID: 17585311 [TBL] [Abstract][Full Text] [Related]
44. Molecular architecture of photoreceptor phosphodiesterase elucidated by chemical cross-linking and integrative modeling. Zeng-Elmore X; Gao XZ; Pellarin R; Schneidman-Duhovny D; Zhang XJ; Kozacka KA; Tang Y; Sali A; Chalkley RJ; Cote RH; Chu F J Mol Biol; 2014 Nov; 426(22):3713-3728. PubMed ID: 25149264 [TBL] [Abstract][Full Text] [Related]
45. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation. Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295 [TBL] [Abstract][Full Text] [Related]
46. Phosphodiesterase 3 and 5 and cyclic nucleotide-gated ion channel expression in rat trigeminovascular system. Kruse LS; Sandholdt NT; Gammeltoft S; Olesen J; Kruuse C Neurosci Lett; 2006 Aug; 404(1-2):202-7. PubMed ID: 16808996 [TBL] [Abstract][Full Text] [Related]
47. Cyclic nucleotide specific phosphodiesterases of Leishmania major. Johner A; Kunz S; Linder M; Shakur Y; Seebeck T BMC Microbiol; 2006 Mar; 6():25. PubMed ID: 16522215 [TBL] [Abstract][Full Text] [Related]
48. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788 [TBL] [Abstract][Full Text] [Related]
49. Structural determinants of phosphodiesterase 6 response on binding catalytic site inhibitors. Simon A; Barabás P; Kardos J Neurochem Int; 2006 Aug; 49(3):215-22. PubMed ID: 16519963 [TBL] [Abstract][Full Text] [Related]
50. The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy. Mehrotra N; Gupta M; Kovar A; Meibohm B Int J Impot Res; 2007; 19(3):253-64. PubMed ID: 16988721 [TBL] [Abstract][Full Text] [Related]
51. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5. Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342 [TBL] [Abstract][Full Text] [Related]
52. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system. Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794 [TBL] [Abstract][Full Text] [Related]
53. Comparison of different heterocyclic scaffolds as substrate analog PDE5 inhibitors. Haning H; Niewöhner U; Schenke T; Lampe T; Hillisch A; Bischoff E Bioorg Med Chem Lett; 2005 Sep; 15(17):3900-7. PubMed ID: 15993055 [TBL] [Abstract][Full Text] [Related]
54. Coexpression, copurification, crystallization and preliminary X-ray analysis of a complex of ARL2-GTP and PDE delta. Renault L; Hanzal-Bayer M; Hillig RC Acta Crystallogr D Biol Crystallogr; 2001 Aug; 57(Pt 8):1167-70. PubMed ID: 11468408 [TBL] [Abstract][Full Text] [Related]
55. Translational regulation of the rod photoreceptor cGMP-phosphodiesterase: the role of the 5'- and 3'-untranslated regions. Piri N; Mendoza E; Shih J; Yamashita CK; Akhmedov NB; Farber DB Exp Eye Res; 2006 Oct; 83(4):841-8. PubMed ID: 16765946 [TBL] [Abstract][Full Text] [Related]
56. Ribozyme knockdown of the gamma-subunit of rod cGMP phosphodiesterase alters the ERG and retinal morphology in wild-type mice. Liu J; Timmers AM; Lewin AS; Hauswirth WW Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3836-44. PubMed ID: 16186371 [TBL] [Abstract][Full Text] [Related]
57. Critical amino acids in phosphodiesterase-5 catalytic site that provide for high-affinity interaction with cyclic guanosine monophosphate and inhibitors. Zoraghi R; Francis SH; Corbin JD Biochemistry; 2007 Nov; 46(47):13554-63. PubMed ID: 17979301 [TBL] [Abstract][Full Text] [Related]
58. Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value? Albrecht K; Uckert S; Oelke M; Andersson KE; Jonas U; Tröger HD; Hedlund P J Forensic Leg Med; 2007 Jul; 14(5):270-4. PubMed ID: 17113813 [TBL] [Abstract][Full Text] [Related]
59. Cyclic nucleotide-specific phosphodiesterases of Plasmodium falciparum: PfPDEalpha, a non-essential cGMP-specific PDE that is an integral membrane protein. Wentzinger L; Bopp S; Tenor H; Klar J; Brun R; Beck HP; Seebeck T Int J Parasitol; 2008 Dec; 38(14):1625-37. PubMed ID: 18590734 [TBL] [Abstract][Full Text] [Related]
60. Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide. Hotston MR; Jeremy JY; Bloor J; Koupparis A; Persad R; Shukla N BJU Int; 2007 Mar; 99(3):612-8. PubMed ID: 17176295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]